CLPT
Clearpoint Neuro IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$403.06M
P/E Ratio
—
EPS
$-1.00
Beta
1.31
52W High
$30.10
52W Low
$8.27
50-Day MA
$11.53
200-Day MA
$14.27
Dividend Yield
—
Profit Margin
-71.60%
Forward P/E
12.11
PEG Ratio
0.60
About Clearpoint Neuro Inc
ClearPoint Neuro, Inc. is a medical device company primarily in the United States. The company is headquartered in Irvine, California.
Fundamentals
| Revenue (TTM) | $40.61M |
| Gross Profit (TTM) | $25.32M |
| EBITDA | $-23.61M |
| Operating Margin | -69.90% |
| Return on Equity | -149.70% |
| Return on Assets | -25.00% |
| Revenue/Share (TTM) | $1.41 |
| Book Value | $0.63 |
| Price-to-Book | 22.03 |
| Price-to-Sales (TTM) | 9.92 |
| EV/Revenue | 10.91 |
| EV/EBITDA | -7.07 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 42.90% |
| Shares Outstanding | $29.99M |
| Float | $26.25M |
| % Insiders | 8.45% |
| % Institutions | 50.60% |
Historical Volatility
HV 10-Day
82.96%
HV 20-Day
77.02%
HV 30-Day
72.35%
HV 60-Day
76.41%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($22.00 target)
3
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026